| Print
Smith & Nephew plc (SNN)
EquityOpen
$26.61
Previous close
$26.80
Trade high
$27.04
Volume
793,263
Year high
$31.72
Year low
$23.69
Dividend yield
2.8%
Market capitalisation
$11.78 bn
P/E ratio
28.51
ISIN
US83175M2052
This share can be held in a Dealing accountSIPP
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 04/10/2024 | 28/03/2025 |
| Ex-dividend date | 04/10/2024 | 28/03/2025 |
| Payment date | 08/11/2024 | 28/05/2025 |
| Amount | $0.288 | $0.462 |
Company profile
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.